Cargando…
A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses
The aim of this study was the development of a software tool (SCRcalc) for the automatic estimation of the patient- and organ-specific cancer risk due to radiotherapy. SCRcalc was developed using the Python 3.8.7 programming language. It incorporates equations and parameters of mechanistic models fo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989449/ https://www.ncbi.nlm.nih.gov/pubmed/35402031 http://dx.doi.org/10.5603/RPOR.a2022.0014 |
_version_ | 1784683175753023488 |
---|---|
author | Tzanis, Eleftherios Mazonakis, Michael Damilakis, John |
author_facet | Tzanis, Eleftherios Mazonakis, Michael Damilakis, John |
author_sort | Tzanis, Eleftherios |
collection | PubMed |
description | The aim of this study was the development of a software tool (SCRcalc) for the automatic estimation of the patient- and organ-specific cancer risk due to radiotherapy. SCRcalc was developed using the Python 3.8.7 programming language. It incorporates equations and parameters of mechanistic models for the calculation of the organ equivalent dose (OED), the excess absolute risk (EA R) and the lifetime attributable risk (LA R) of carcinogenesis for various organs due to radiotherapy. Data from differential dose-volume histograms, as defined by a treatment planning system, could be automatically inserted into the program. Eighteen different cancer risk estimates for various organs were performed of patients subjected to radiation therapy with conventional and modulated techniques. These software estimates were compared with manual calculations. SCRcalc was developed as a standalone executable program without any dependencies. It enables direct estimations of the OED and LAR for various organs at risk. An important aspect of the software is that it does not require pre-processing of the DVH data. No differences were found between the SCRcalc results and those derived from manual calculations. The newly developed software offers the possibility to medical physicists and radiation oncologists to directly estimate the probability of radiotherapy-induced secondary malignancies for various organs at risk. |
format | Online Article Text |
id | pubmed-8989449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Via Medica |
record_format | MEDLINE/PubMed |
spelling | pubmed-89894492022-04-08 A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses Tzanis, Eleftherios Mazonakis, Michael Damilakis, John Rep Pract Oncol Radiother Technical Note The aim of this study was the development of a software tool (SCRcalc) for the automatic estimation of the patient- and organ-specific cancer risk due to radiotherapy. SCRcalc was developed using the Python 3.8.7 programming language. It incorporates equations and parameters of mechanistic models for the calculation of the organ equivalent dose (OED), the excess absolute risk (EA R) and the lifetime attributable risk (LA R) of carcinogenesis for various organs due to radiotherapy. Data from differential dose-volume histograms, as defined by a treatment planning system, could be automatically inserted into the program. Eighteen different cancer risk estimates for various organs were performed of patients subjected to radiation therapy with conventional and modulated techniques. These software estimates were compared with manual calculations. SCRcalc was developed as a standalone executable program without any dependencies. It enables direct estimations of the OED and LAR for various organs at risk. An important aspect of the software is that it does not require pre-processing of the DVH data. No differences were found between the SCRcalc results and those derived from manual calculations. The newly developed software offers the possibility to medical physicists and radiation oncologists to directly estimate the probability of radiotherapy-induced secondary malignancies for various organs at risk. Via Medica 2022-03-22 /pmc/articles/PMC8989449/ /pubmed/35402031 http://dx.doi.org/10.5603/RPOR.a2022.0014 Text en © 2022 Greater Poland Cancer Centre https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially |
spellingShingle | Technical Note Tzanis, Eleftherios Mazonakis, Michael Damilakis, John A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses |
title | A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses |
title_full | A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses |
title_fullStr | A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses |
title_full_unstemmed | A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses |
title_short | A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses |
title_sort | software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses |
topic | Technical Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989449/ https://www.ncbi.nlm.nih.gov/pubmed/35402031 http://dx.doi.org/10.5603/RPOR.a2022.0014 |
work_keys_str_mv | AT tzaniseleftherios asoftwaretoolfororganspecificsecondcancerriskassessmentfromexposuretotherapeuticdoses AT mazonakismichael asoftwaretoolfororganspecificsecondcancerriskassessmentfromexposuretotherapeuticdoses AT damilakisjohn asoftwaretoolfororganspecificsecondcancerriskassessmentfromexposuretotherapeuticdoses AT tzaniseleftherios softwaretoolfororganspecificsecondcancerriskassessmentfromexposuretotherapeuticdoses AT mazonakismichael softwaretoolfororganspecificsecondcancerriskassessmentfromexposuretotherapeuticdoses AT damilakisjohn softwaretoolfororganspecificsecondcancerriskassessmentfromexposuretotherapeuticdoses |